相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival - A report from the Children's Oncology Group
Paul A. Meyers et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma
Nita L. Seibel et al.
CANCER (2007)
Liposomal muramyl tripeptide phosphatidylethanolamine:: Targeting and activating macrophages for adjuvant treatment of osteosarcoma
A Nardin et al.
CURRENT CANCER DRUG TARGETS (2006)
A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma
A McTiernan et al.
PEDIATRIC BLOOD & CANCER (2006)
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy - 15-year experience in 789 patients treated at a single institution
G Bacci et al.
CANCER (2006)
Metastatic osteosarcoma - Results of two consecutive therapeutic trials at St. Jude Children's Research Hospital
NC Daw et al.
CANCER (2006)
Metastatic osteosarcoma at diagnosis - Prognostic factors and long-term outcome - The French pediatric experience
V Mialou et al.
CANCER (2005)
Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate
PA Meyers et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Long-term survival in high-grade axial osteosarcoma with bone and lung metastases treated with chemotherapy only
AB del Prever et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)
Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide
G Bacci et al.
ANNALS OF ONCOLOGY (2003)
Primary metastatic osteosarcoma:: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols
L Kager et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII:: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders
S Smeland et al.
EUROPEAN JOURNAL OF CANCER (2003)